Ruhnke L, Röllig C, Herold S, Sauer T, Brandts CH, Steffen B, Schäfer-Eckart K, Krause S, Hänel M, Reichle A, Scholl S, Neubauer A, Mikesch JH, Schetelig J, Stölzel F, Kramer M, Haake A, Frimmel J, Krämer A, Schlenk R, Platzbecker U, Serve H, Baldus CD, Müller-Tidow C, Aust D, Bornhäuser M, Ehninger G, Thiede C (2023)
Publication Type: Journal article
Publication year: 2023
Book Volume: 108
Pages Range: 2520-2525
Journal Issue: 9
DOI: 10.3324/haematol.2022.281636
APA:
Ruhnke, L., Röllig, C., Herold, S., Sauer, T., Brandts, C.H., Steffen, B.,... Thiede, C. (2023). Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial. Haematologica, 108(9), 2520-2525. https://doi.org/10.3324/haematol.2022.281636
MLA:
Ruhnke, Leo, et al. "Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial." Haematologica 108.9 (2023): 2520-2525.
BibTeX: Download